WALTHAM, Mass., May 25 /PRNewswire-FirstCall/ -- Inverness
Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling
individuals to take charge of their health at home through the
merger of rapid diagnostics and health management, has declared a
dividend of $3.00 per share on its
Series B Convertible Perpetual Preferred Stock (NYSE: IMA-PB).
The dividend will be paid in shares of Series B stock in an
amount per share equal to the quotient of (a) $3.00 divided by (b) 97% of the average of the
volume-weighted average price per share of the Series B stock on
the New York Stock Exchange for each of the five consecutive
trading days ending on the second trading day immediately prior to
the record date of the dividend. Inverness will pay cash in
lieu of any fractional shares resulting from the dividend.
The dividend is payable on July 15,
2010 to holders of record of Series B stock at the close of
business on July 1, 2010.
Such payment will cover the amount of all dividends accrued from
April 1, 2010 through June 30, 2010.
For more information about Inverness Medical Innovations,
please visit our website at
http://www.invernessmedical.com.
By developing new capabilities in near-patient diagnosis,
monitoring and health management, Inverness Medical Innovations
enables individuals to take charge of improving their health and
quality of life. Inverness' global leading products and
services, as well as its new product development efforts, focus on
infectious disease, cardiology, oncology, drugs of abuse and
women's health. Inverness is headquartered in Waltham, Massachusetts.
SOURCE Inverness Medical Innovations, Inc.